S&P 500
(0.17%) 5 108.38 points
Dow Jones
(0.27%) 38 342 points
Nasdaq
(0.22%) 15 962 points
Oil
(-1.32%) $82.74
Gas
(6.34%) $2.05
Gold
(-0.08%) $2 345.30
Silver
(-0.25%) $27.47
Platinum
(3.95%) $958.55
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.33%) $10.99
USD/GBP
(-0.53%) $0.796
USD/RUB
(1.66%) $93.40

Sanntidsoppdatering for PerkinElmer Inc [PKI]

Børs: NYSE Sektor: Healthcare Industri: Diagnostics & Research
Sist oppdatert15 mai 2023 @ 22:03

-0.91% $ 115.24

Live Chart Being Loaded With Signals

Commentary (15 mai 2023 @ 22:03):

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...

Stats
Dagens volum 1.63M
Gjennomsnittsvolum 808 389
Markedsverdi 14.46B
EPS $0 ( 2024-02-12 )
Neste inntjeningsdato ( $0 ) 2024-05-09
Last Dividend $0.0700 ( 2023-07-20 )
Next Dividend $0 ( N/A )
P/E 41.45
ATR14 $3.13 (2.60%)
Insider Trading
Date Person Action Amount type
2023-12-15 Gonzales Anita Buy 248 Common Stock
2023-12-15 Gonzales Anita Buy 706 NQ Stock Option (right to buy)
2023-11-27 Michas Alexis P Sell 250 Common Stock
2023-11-28 Michas Alexis P Sell 230 Common Stock
2023-06-15 Gonzales Anita Buy 329 Common Stock
INSIDER POWER
28.89
Last 100 transactions
Buy: 270 652 | Sell: 165 378

Volum Korrelasjon

Lang: -0.22 (neutral)
Kort: -0.12 (neutral)
Signal:(41.494) Neutral

PerkinElmer Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PerkinElmer Inc Korrelasjon - Valuta/Råvare

The country flag 0.25
( neutral )
The country flag -0.36
( neutral )
The country flag 0.01
( neutral )
The country flag -0.02
( neutral )
The country flag -0.53
( weak negative )
The country flag -0.19
( neutral )

PerkinElmer Inc Økonomi

Annual 2022
Omsetning: $3.31B
Bruttogevinst: $1.99B (60.08 %)
EPS: $4.59
FY 2022
Omsetning: $3.31B
Bruttogevinst: $1.99B (60.08 %)
EPS: $4.59
FY 2022
Omsetning: $3.31B
Bruttogevinst: $1.99B (60.08 %)
EPS: $4.59
FY 2021
Omsetning: $5.07B
Bruttogevinst: $2.85B (56.27 %)
EPS: $7.39

Financial Reports:

No articles found.

PerkinElmer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0.0700
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

PerkinElmer Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.50 - good (94.96%) | Divividend Growth Potential Score: 2.99 - Decrease likely (40.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0225 1983-04-18
Last Dividend $0.0700 2023-07-20
Next Dividend $0 N/A
Payout Date 2023-08-11
Next Payout Date N/A
# dividends 164 --
Total Paid Out $10.25 --
Avg. Dividend % Per Year 0.11% --
Score 4.42 --
Div. Sustainability Score 9.50
Div.Growth Potential Score 2.99
Div. Directional Score 6.24 --
Next Divdend (Est)
(2024-07-01)
$0.0705 Estimate 22.45 %
Dividend Stability
0.60 Average
Dividend Score
4.42
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1983 $0.0675 1.00%
1984 $0.100 1.24%
1985 $0.120 1.52%
1986 $0.130 1.36%
1987 $0.140 1.98%
1988 $0.150 1.78%
1989 $0.170 2.38%
1990 $0.190 2.20%
1991 $0.210 2.66%
1992 $0.245 2.03%
1993 $0.325 3.27%
1994 $0.280 3.15%
1995 $0.350 4.79%
1996 $0.280 2.35%
1997 $0.280 2.82%
1998 $0.280 2.68%
1999 $0.280 1.94%
2000 $0.280 1.35%
2001 $0.280 0.58%
2002 $0.280 0.80%
2003 $0.280 3.17%
2004 $0.280 1.60%
2005 $0.280 1.27%
2006 $0.280 1.17%
2007 $0.280 1.28%
2008 $0.280 1.10%
2009 $0.280 1.98%
2010 $0.280 1.36%
2011 $0.280 1.08%
2012 $0.280 1.36%
2013 $0.280 0.87%
2014 $0.280 0.68%
2015 $0.280 0.64%
2016 $0.280 0.53%
2017 $0.280 0.53%
2018 $0.280 0.38%
2019 $0.280 0.36%
2020 $0.280 0.28%
2021 $0.280 0.19%
2022 $0.280 0.15%
2023 $0.210 0.15%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
VGI Dividend Royal 2024-02-09 Monthly 13 7.36% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07901.5008.4210.00[0 - 0.5]
returnOnAssetsTTM0.01181.2009.6110.00[0 - 0.3]
returnOnEquityTTM0.02161.500-0.871-1.306[0.1 - 1]
payoutRatioTTM0.0527-1.0009.47-9.47[0 - 1]
currentRatioTTM2.580.8002.111.689[1 - 3]
quickRatioTTM1.9740.8003.102.48[0.8 - 2.5]
cashRatioTTM0.9741.5005.708.55[0.2 - 2]
debtRatioTTM0.317-1.5004.72-7.08[0 - 0.6]
interestCoverageTTM5.121.0009.219.21[3 - 30]
operatingCashFlowPerShareTTM1.6162.009.4610.00[0 - 30]
freeCashFlowPerShareTTM1.2402.009.3810.00[0 - 20]
debtEquityRatioTTM0.573-1.5007.71-10.00[0 - 2.5]
grossProfitMarginTTM0.5891.0003.513.51[0.2 - 0.8]
operatingProfitMarginTTM0.1251.0009.519.51[0.1 - 0.6]
cashFlowToDebtRatioTTM0.04501.000-0.861-0.861[0.2 - 2]
assetTurnoverTTM0.1490.800-2.34-1.870[0.5 - 2]
Total Score9.50

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM86.071.0001.4070[1 - 100]
returnOnEquityTTM0.02162.50-0.560-1.306[0.1 - 1.5]
freeCashFlowPerShareTTM1.2402.009.5910.00[0 - 30]
dividendYielPercentageTTM0.06071.5008.480[0 - 0.4]
operatingCashFlowPerShareTTM1.6162.009.4610.00[0 - 30]
payoutRatioTTM0.05271.5009.47-9.47[0 - 1]
pegRatioTTM-1.9801.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.09531.000-0.1160[0.1 - 0.5]
Total Score2.99

PerkinElmer Inc

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.